deeptech Value proposition
[Automatic translation follows] The BioPark pools resources and skills in the field of life sciences.
Our technological platform brings together cutting-edge equipment and expertise to support a community of researchers from public and private teams. While developing its own R&D activities, the BioPark offers services (MassOmics service), access to its instrumental infrastructure and national and international collaborative projects.
The Nursery welcomes Biotechnology companies. The BioPark Platform Association has the Research Tax Credit (CIR) approval.
Mass spectrometry, Bioanalyses, Proteomics, Metabolomics, Omics, Biotechnology, Nursery, Ecotoxicology, Biological matrices, Chronic infection, Disease, Bioactive molecules, Histoproteomics, and Study of BiodiversityOriginal language
Le BioPark met en commun des moyens et des compétences dans le domaine des sciences du vivant.
Notre plateforme technologique regroupe équipements de pointe et expertises en appui à une communauté de chercheurs issue d’équipes publiques et privées. Tout en développant ses propres activités de R&D, le BioPark propose des services (service MassOmics), des accès à son infrastructure instrumentale et des projets collaboratifs nationaux et internationaux.
La Pépinière accueille des entreprises de Biotechnologies. L’Association Plateforme BioPark dispose de l’agrément Crédit Impôt Recherche (CIR).
Mass spectrometry, Bioanalyses, Proteomics, Metabolomics, Omics, Biotechnology, Nursery, Ecotoxicology, Biological matrices, Chronic infection, Disease, Bioactive molecules, Histoproteomics, and Study of Biodiversity
BioParkArchamps | Plateforme Technologique connexe à une Pépinière
https://www.biopark-archamps.org/ - Website is disabled or domain is for sale
| Corporate | Type | Tweets | Articles | |
|---|---|---|---|---|
 Take-Off.io International Trade and Development | Take-Off.io International Trade and Development | Other 20 Nov 2022 | | |
 ArchParc Startup accelerator & VC | ArchParc Startup accelerator & VC | Other 25 Jul 2024 | | |